Sanofi (SNY) reported Q4 adjusted earnings Thursday of 1.53 euros ($1.83) per share, up from 1.31 euros a year earlier.
Analysts polled by FactSet expected 1.45 euros.
Net sales for the quarter ended Dec. 31 were 11.30 billion euros, up from 10.56 billion euros a year earlier.
Analysts surveyed by FactSet expected 11.62 billion euros.
For 2026, the drugmaker said it expects high single-digit percentage sales growth at constant exchange rates, with adjusted EPS expected to grow "slightly faster than sales."
The company also said it plans to execute a one billion euro share buyback in 2026.
Shares of the company were up 1% in recent premarket activity.
Comments